| General Information of Drug Metabolite (DM) (ID: DM019689) |
| DM Name |
PHA-739358 N-oxide metabolite
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Dimethylaniline oxidase 3 (FMO3)
|
DME0039
|
| Oxidation - N-oxidation |
PHA-739358
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| PHA-739358 |
DR3202
|
Phase 2 |
Prostate cancer |
|
|
| References |
| 1 |
Effect of human flavin-containing monooxygenase 3 polymorphism on the metabolism of aurora kinase inhibitors
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
